Sylvia Haas

13.2k citations

209 papers · 9.1k indexed · 5 hit papers · h-index 43

Impact in

Internal Medicine top 0.02%
- Venous Thromboembolism Diagnosis and Management
Cardiology and Cardiovascular Medicine top 0.1%
- Atrial Fibrillation Management and Outcomes
- Cardiac Arrhythmias and Treatments
- Antiplatelet Therapy and Cardiovascular Diseases
- Acute Myocardial Infarction Research

Papers in

Internal Medicine 152
- Venous Thromboembolism Diagnosis and Management 152
Cardiology and Cardiovascular Medicine 159
- Atrial Fibrillation Management and Outcomes 135
- Cardiac Arrhythmias and Treatments 36
- Acute Myocardial Infarction Research 35
- Antiplatelet Therapy and Cardiovascular Diseases 30

Co-authors: Ajay K. Kakkar Frank Misselwitz Bengt I. Eriksson Menno V. Huisman Lars C. Borris Samuel Z. Goldhaber Ola E. Dahl LG Mantovani
Journals: Thrombosis and Haemostasis (19 papers)Thrombosis Research (13 papers)Blood (11 papers)European Heart Journal (8 papers)Journal of Thrombosis and Haemostasis (6 papers)
Partner nations: Germany Canada United Kingdom

In The Last Decade

Sylvia Haas

199 papers receiving 8.7k citations

Hit Papers

5 papers align trajectories log scale

XANTUS: a real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation 2015 · 331 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2015 European Heart Journal
2013 PLoS ONE
2011 New England Journal of Medicine
2008 The Lancet
2008 New England Journal of Medicine

Peers

Countries citing papers authored by Sylvia Haas

Since Specialization

Citations

This map shows the geographic impact of Sylvia Haas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvia Haas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvia Haas more than expected).

Fields of papers citing papers by Sylvia Haas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvia Haas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvia Haas. The network helps show where Sylvia Haas may publish in the future.

Co-authors

The 25 scholars most cited alongside Sylvia Haas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sylvia Haas Line = papers co-authored together Sylvia Haas links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Sex differences in venous thromboembolism outcomes: findings from the GARFIELD-VTE registry European Journal of Internal Medicine ·Paolo Prandoni, Meg Fluharty, Sebastian Schellong, Henri Bounameaux, Sylvia Haas, LG Mantovani, I Allekotte, Katsuhiro Kondo, Harry Gibbs, Zhi‐Cheng Jing, Chern‐En Chiang, Peter Verhamme, Alexander GG Turpie, Jeffrey I. Weitz, Walter Ageno, Shinya Goto, Pantep Angchaisuksiri, Karen S. Pieper, Ajay K. Kakkar	2025	0
2	Impact of patient selection in clinical trials: application of ROCKET AF and ARISTOTLE criteria in GARFIELD-AF Open Heart ·Jelle C L Himmelreich, Saverio Virdone, A. John Camm, Karen S. Pieper, Ralf E. Harskamp, Ali̇ Oto, Barry Jacobson, J.P.S. Sawhney, Toon Wei Lim, Harry Gibbs, Shinya Goto, Sylvia Haas, Keith A.A. Fox, Petr Janský, Freek W.A. Verheugt, Ajay K. Kakkar	2024	0
3	Rhythm versus rate control in patients with newly diagnosed atrial fibrillation – Observations from the GARFIELD-AF registry IJC Heart & Vasculature ·P K Resmi, Trygve S. Hall, Saverio Virdone, Dan Atar, A. John Camm, Karen S. Pieper, Petr Janský, Sylvia Haas, Shinya Goto, Е. П. Панченко, Gonzalo Barón‐Esquivias, Pantep Angchaisuksiri, Ajay K. Kakkar	2023	3
4	Oral anticoagulation across diabetic subtypes in patients with newly diagnosed atrial fibrillation: A report from the GARFIELD‐AF registry Diabetes Obesity and Metabolism ·Jean‐Pierre Bassand, Saverio Virdone, A. John Camm, Keith A.A. Fox, Samuel Z. Goldhaber, Shinya Goto, Sylvia Haas, Werner Hacke, Gloria Kayani, Mátyás Keltai, Frank Misselwitz, Karen S. Pieper, Alexander G.G. Turpie, Freek W.A. Verheugt, Ajay K. Kakkar, (unknown)	2023	1
5	Guideline-directed medical therapies for comorbidities among patients with atrial fibrillation: results from GARFIELD-AF European Heart Journal Open ·Alan John Camm, Jan Steffel, Saverio Virdone, Jean‐Pierre Bassand, Keith A.A. Fox, Samuel Z. Goldhaber, Shinya Goto, Sylvia Haas, Alexander G. G. Turpie, Freek W.A. Verheugt, Frank Misselwitz, KAJAL D. BHOYAR, Gloria Kayani, Karen S. Pieper, Ajay K. Kakkar, (unknown)	2023	3
6	Critical appraisal and issues regarding generalisability of comparative effectiveness studies of NOACs in atrial fibrillation and their relation to clinical trial data: a systematic review BMJ Open ·Eveline M. Bunge, Ben van Hout, Sylvia Haas, Georgios Spentzouris, Alexander T. Cohen	2021	1
7	GARFIELD-AF risk score for mortality, stroke, and bleeding within 2 years in patients with atrial fibrillation European Heart Journal - Quality of Care and Clinical Outcomes ·Keith A.A. Fox, Saverio Virdone, Karen S. Pieper, Jean‐Pierre Bassand, A. John Camm, David Fitzmaurice, Samuel Z. Goldhaber, Shinya Goto, Sylvia Haas, Gloria Kayani, Ali̇ Oto, Frank Misselwitz, Jonathan P. Piccini, Frederik Dalgaard, Alexander G. G. Turpie, Freek W.A. Verheugt, Ajay K. Kakkar, (unknown)	2021	27
8	Comparative effectiveness of oral anticoagulants in venous thromboembolism: GARFIELD-VTE Thrombosis Research ·Henri Bounameaux, Sylvia Haas, Alfredo E. Farjat, Walter Ageno, Jeffrey I. Weitz, Samuel Z. Goldhaber, Alexander G.G. Turpie, Shinya Goto, Pantep Angchaisuksiri, Joern Dalsgaard Nielsen, Gloria Kayani, Sebastian Schellong, LG Mantovani, Paolo Prandoni, Ajay K. Kakkar	2020	18
9	Thrombotic and hemorrhagic burden in women: Gender-related issues in the response to antithrombotic therapies International Journal of Cardiology ·Giulia Renda, Giuseppe Patti, Iréne Lang, Jolanta M. Siller‐Matula, Elaine M. Hylek, Giuseppe Ambrosio, Sylvia Haas, Raffaele De Caterina	2019	21
10	Why do clinicians withhold anticoagulation in patients with atrial fibrillation and CHA2DS2-VASc score ≥ 2? Archives of Cardiovascular Diseases Supplements ·Alison Martin, Deborah Siegal, Frederik H. Verbrugge, António Fiarresga, A. John Camm, KS Pieper, Fabián Alirio Mazo Elorza, Jean‐Pierre Bassand, Sylvia Haas, Samuel Z. Goldhaber, A.K. Kakkar	2018	3
11	A Pooled Analysis of the Xalia and Xalia-Lea Non-Interventional Studies of Rivaroxaban Versus Standard Anticoagulation in Venous Thromboembolism Blood ·Alexander G.G. Turpie, LG Mantovani, Sylvia Haas, Reinhold Kreutz, 瞳魚谷, Jonas Schneider, Martin van Eickels, Miriam Tamm, Martin Gebel, Walter Ageno	2017	2
12	Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation BMJ Open ·Keith A.A. Fox, Joseph E. Lucas, Karen S. Pieper, Jean‐Pierre Bassand, A. John Camm, David Fitzmaurice, Samuel Z. Goldhaber, Shinya Goto, Sylvia Haas, Werner Hacke, Gloria Kayani, Ali̇ Oto, LG Mantovani, Frank Misselwitz, Jonathan P. Piccini, Alexander G.G. Turpie, Freek W.A. Verheugt, Ajay K. Kakkar	2017	88
13	Impact of gender on event rates at 1 year in patients with newly diagnosed non-valvular atrial fibrillation: contemporary perspective from the GARFIELD-AF registry BMJ Open ·A. John Camm, Gabriele Accetta, Wael Al Mahmeed, Giuseppe Ambrosio, Samuel Z. Goldhaber, Sylvia Haas, Petr Janský, Gloria Kayani, Frank Misselwitz, Seil Oh, Ali̇ Oto, Pekka Raatikainen, Jan Steffel, Martin van Eickels, Ajay K. Kakkar	2017	31
14	Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF European Heart Journal ·Jean‐Pierre Bassand, Gabriele Accetta, Alan John Camm, Frank Cools, David Fitzmaurice, Keith A.A. Fox, Samuel Z. Goldhaber, Shinya Goto, Sylvia Haas, Werner Hacke, Gloria Kayani, LG Mantovani, Frank Misselwitz, Hugo Ten Cate, Alexander G.G. Turpie, Freek W.A. Verheugt, Ajay K. Kakkar	2016	196
15	Venous thromboembolism: Prophylactic and therapeutic practice guideline South African Medical Journal ·Barry Jacobson, Susan Louw, Harry R. Büller, Hasan Abdulrazzaq Al Sanjary, P.R. De Jong, Benjamin Tom, Elise Schapkaitz, Dan Adler, Wegbom Anthony Ike, Hsu Hc, P. L. WESSELS, Sylvia Haas	2013	43
16	Thromboseprophylaxe in der Chirurgie: Was ist wirklich gesichert? Chirurg ·Sylvia Haas, A. Encke, R. Krauspe, Christian Waydhas	2011	1
17	Rivaroxaban for thromboprophylaxis after orthopaedic surgery: Pooled analysis of two studies Thrombosis and Haemostasis ·Bengt I. Eriksson, Kenneth A. Bauer, Lars C. Borris, Ola E. Dahl, Michael Gent, Sylvia Haas, Martin Homering, Menno V. Huisman, Ajay K. Kakkar, Peter Kälebo, Louis M. Kwong, Frank Misselwitz, Alexander G.G. Turpie, William D. Fisher	2007	56
18	The Prothrombinase-Induced Clotting Test: A New Technique for the Monitoring of Anticoagulants Pathophysiology of Haemostasis and Thrombosis ·M Nimalan, M. Spannagl, Antarctic Climate Research Planning, Hans-Jürgen Kolde, W Schramm, Sylvia Haas	2000	21
19	First Workshop for Detection of Heparin-induced Antibodies: Validation of the Heparin-induced Platelet-activation Test (HIPA) in Comparison with a PF4/Heparin ELISA Thrombosis and Haemostasis ·Petra Eichler, U. Budde, Sylvia Haas, H. Kroll, Yuanming Zhai, Oliver Meyer, Ulrich Pachmann, B. Pötzsch, 杨生辉, Doris Albrecht, Andreas Greinacher	1999	127
20	[Effects of heparin, sulfinpyrazone and acetylsalicylic acid on the collagen-induced thromboyte aggregation]. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Sylvia Haas, Sylweriusz Kosiński, L Chen, Thomas Gaertner, G. Blümel	1979	1

About Sylvia Haas

Sylvia Haas is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine, Hematology, Emergency Medical Services and Surgery, having authored 209 papers that have together received 9.1k indexed citations. Recurring topics across this work include Venous Thromboembolism Diagnosis and Management (152 papers), Atrial Fibrillation Management and Outcomes (135 papers), Cardiac Arrhythmias and Treatments (36 papers), Acute Myocardial Infarction Research (35 papers), Antiplatelet Therapy and Cardiovascular Diseases (30 papers), Heparin-Induced Thrombocytopenia and Thrombosis (25 papers), Blood Coagulation and Thrombosis Mechanisms (21 papers) and Clinical practice guidelines implementation (11 papers). The work is most often cited by research in Internal Medicine (6.4k citations), Cardiology and Cardiovascular Medicine (7.2k citations), Hematology (1.2k citations), Emergency Medical Services (537 citations) and Surgery (1.8k citations). Sylvia Haas has collaborated with scholars based in Germany, Canada and United Kingdom. Frequent co-authors include Ajay K. Kakkar, Frank Misselwitz, Bengt I. Eriksson, Menno V. Huisman, Lars C. Borris, Samuel Z. Goldhaber, Ola E. Dahl, LG Mantovani, Eva Muehlhofer and Martin van Eickels. Their work appears in journals such as Thrombosis and Haemostasis, Thrombosis Research, Blood, European Heart Journal and Journal of Thrombosis and Haemostasis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact